Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
NCT: NCT07352566 · NOT_YET_RECRUITING
Brief Summary
This study is being done to test a microdevice, which is a small device designed to test drugs directly on skin conditions like atopic dermatitis (eczema) and psoriasis. The small device, about the size of a grain of rice, has up to 20 tiny reservoirs that hold medications that are approved by the Food and Drug Administration (FDA) for atopic dermatitis and psoriasis. Very small amounts of these medications will be released into the skin (at levels in your body much lower than are typically used). In this study, the device will be tested to see if it's safe and works well for predicting how the skin will react to standard treatments. We will also look at how these reactions are connected to genetic information and overall treatment results.
Frequently Asked Questions
What is Utilization of a Microdevice for Psoriasis and Atopic Dermatitis?
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis is a clinical trial registered under NCT07352566. Current status: NOT_YET_RECRUITING.
What is the status of NCT07352566?
The current status of NCT07352566 (Utilization of a Microdevice for Psoriasis and Atopic Dermatitis) is: NOT_YET_RECRUITING.
When did Utilization of a Microdevice for Psoriasis and Atopic Dermatitis start?
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis started on 2026-08-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.